Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours ยท Estimated delivery Sep 16 - Sep 21
glp 1 concerns GLP-1 Medications Infographic GLP-1 Analogues Market Driven format:powder Pack Size:Duo Pack (๐ฅ Hot Deal: Save $78)
GLP-1 Analogues Market Driven by Diabetes Obesity Therapeutics | Core Pharma & Biotech posted on the topic | LinkedIn
Israelsen, et al
format:powder
Pack Size:Duo Pack (๐ฅ Hot Deal: Save $78)
Industry Size (2025) USD 8169 Mn Forecast (2035) USD 65364 Mn CAGR (2025 to 2035) 23.1% Obesity GLP-1 Market Forecast and Outlook 2025 to 2035 The obesity GLP-1 market is projected to grow from USD 8169 million in 2025 to approximately USD 65,364 million by 2035, recording an absolute increase of USD 57,195 million over the forecast period
![PDF] Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide](https://figures.semanticscholar.org/594349790d0e9a09f8b5843f2782af9cfaaa7bf4/37-Figure3-1.png)
